Helicos BioSciences last week for the first time publicly acknowledged that until last year it had been “unable to address homopolymer sequencing,” but said it has found a solution to this problem.
 
In a presentation at last week’s Advances in Genome Biology & Technology conference in Marco Island, Fla., Bill Efcavitch, Helicos’ senior vice president of product research and development, said the company has developed a proprietary nucleotide-polymerase pair where the nucleotides prevent the polymerase from adding more than one base per reacti

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.